MRI after removal of central venous access device reveals a high number of asymptomatic thromboses in children with haemophilia

Haemophilia

Volumn 18, Issue 4, 2012, Pages 521-526

  Ranta, S ^a   Kalajoki Helmio T ^b   Pouttu, J ^a   Makipernaa A ^c  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Central venous access device; Children; Haemophilia; Thrombosis

Indexed keywords

ADOLESCENT; ADULT; ARM CIRCUMFERENCE; ARTICLE; ASYMPTOMATIC DISEASE; CHILD; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; DEVICE INFECTION; DEVICE REMOVAL; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HUMAN; MALE; MEDICAL RECORD REVIEW; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; SKIN INFECTION; THROMBOSIS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE;

ADOLESCENT; ADULT; CATHETERIZATION, CENTRAL VENOUS; CHILD; COAGULANTS; DEVICE REMOVAL; FEMALE; HEMOPHILIA A; HEMOPHILIA B; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 84863200389     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2011.02719.x     Document Type: Article

References (23)

1. Santagostino E, Mancuso ME. Venous access in haemophilic children: choise and management. Haemophilia 2010; 16(Suppl. 1): 20-4.
2. Izzi G, Franchini M, Bonetti L, Tagliaferri A. The use of central venous catheters in haemophilia patients. Haemophilia 2010; 16: 29-31.
3. Titapiwatanakun R, Moir C, Pruthi RK, Stavlo PL, Schmidt KA, Rodriguez V. Central venous access devices for paediatric patients with haemophilia: a single-institution experience. Haemophilia 2009; 15: 168-74.
4. Cost CR, Journeycake JM. Deep venous thrombosis screening in patients with inherited bleeding disorders and central venous catheters. Haemophilia 2011; 17: 890-4.
5. Liesner RJ, Vora AJ, Hann IM, Lilleymann JS. Use of central venous catheters in children with severe congenital coagulopathy. Br J Haematol 1995; 91: 203-7.
6. Miller K, Buchanan GR, Zappa S et al. Implantable venous access devices in children with hemophilia: a report of low infection rates. J Pediatr 1998; 132: 934-8.
7. Ljung R, van den Berg M, Petrini P et al. Port-A-Cath usage in children with haemophilia: experience of 53 cases. Acta Paediatr 1998; 87: 1051-4.
8. Journeycake JM, Quinn CT, Miller KL, Zajac JL, Buchanan GR. Catheter-related deep venous thrombosis in children with hemophilia. Blood 2001; 98: 1727-31.
9. Price VE, Carcao M, Connolly B et al. A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia. J Thromb Haemost 2004; 2: 737-42.
10. Carcao MD. Side-effects and venous access issues with immune tolerance therapy. Haemophilia 2009; 15: 494-500.
11. Komvilaisak P, Connolly B, Naqvi A, Blanchette V. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders. Haemophilia 2006; 6: 87-93.
12. Goldenberg NA, Donadini MP, Kahn SR et al. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica 2010; 95: 1952-9.
13. Kurnik K, Bidlingmaier S, Engl W, Chehadeh H, Reipert B, Auerswald G. New early prophylaxis regimen that avoids immunological danger signals can reduce FVIII inhibitor development. Haemophilia 2010; 16: 256-62.
14. Goldenberg NA, Pounder E, Knapp-Clevenger R, Manco-Johnson MJ. Validation of upper extremity post-thrombotic syndrome outcome measurement in children. J Pediatr 2010; 157: 852-5.
15. Male C, Chait P, Ginsberg JS et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic antithrombin replacement in Kids with ALL treated with Asparaginase. Thromb Haemost 2002; 87: 593-8.
16. Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998; 133: 770-6.
17. Kuhle S, Koloshuk B, Marzinotto V et al. A cross-sectional study evaluating post-thrombotic syndrome in children. Thromb Res 2003; 111: 227-33.
18. Boulden BM, Crary SE, Buchanan GR, Journeycake M. Determination of pediatric norms for assessment of upper venous system post-thrombotic syndrome. J Thromb Haemost 2007; 5: 1077-9.
19. Dunn AL, Abshire TC. Recombinant tissue plasminogen activator may reduce frequency of central venous access device infection in hemophilia patients undergoing immune tolerance therapy. Pediatr Blood Cancer 2008; 50: 627-9.
20. Ragni MN, Journeycake JM, Brambilla DJ. Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis. Haemophilia 2008; 14: 30-8.
21. Jeng MR, O'Brien M, Wong W et al. Monthly recombinant tissue plasminogen activator administration to implantable central venous access devices decreases infections in children with haemophilia. Haemophilia 2009; 15: 1272-80.
22. Valentino LA, Ewenstein B, Navickis RJ, Wilkes MM. Central venous access devices in haemophilia. Haemophilia 2004; 10: 134-46.
23. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003; 9: 418-35.